AbbVie (ABBV)
(Delayed Data from NYSE)
$195.40 USD
-0.52 (-0.27%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $195.10 -0.30 (-0.15%) 7:38 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Brokerage Reports
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 241 - 260 ( 385 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Neurology Prescription Sales Tracker -- Week Ending 4/10/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Neurology Prescription Sales Tracker -- Week Ending 3/06/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Biotechnology: Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 17 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Humira continues to face stiff competition from biosimilars in Europe
Provider: Arrowhead Business and Investment Decisions
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department